Greenshoe

Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Retrieved on: 
Monday, February 1, 2021
Financial markets, Finance, Financial economics, Stock market, Initial public offering, Corporate finance, Equity securities, Options, Prospectus, Warrant, Greenshoe, Ladenburg Thalmann

Ladenburg Thalmann & Co. Inc. acted as the sole bookrunning manager of the offering.

Key Points: 
  • Ladenburg Thalmann & Co. Inc. acted as the sole bookrunning manager of the offering.
  • A total of 744,936 shares of common stock and warrants to purchase up to 372,468 shares of common stock were issued in the offering, including the full exercise of the over-allotment option.
  • A final prospectus relating to this offering was filed by Helius with the SEC.
  • The PoNS is an investigational medical device in the United States, the European Union (EU), and Australia (AUS).

Premier Health Announces $4 Million Bought Deal Financing

Retrieved on: 
Monday, February 1, 2021
Stock market, Greenshoe, Initial public offering, Acumen, Healthcare industry

MONTREAL, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (Premier Health or the Corporation), a leading Canadian Healthtech company, announces today that it has entered into an agreement with Acumen Capital Finance Partners Limited (the Underwriter) to purchase on a bought deal basis 3,810,000 common shares of Premier Health (Common Shares) at a price of $1.05 per Common Share (the Offering Price) for gross proceeds to the Corporation of approximately $4.0 million (the Offering).

Key Points: 
  • MONTREAL, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (Premier Health or the Corporation), a leading Canadian Healthtech company, announces today that it has entered into an agreement with Acumen Capital Finance Partners Limited (the Underwriter) to purchase on a bought deal basis 3,810,000 common shares of Premier Health (Common Shares) at a price of $1.05 per Common Share (the Offering Price) for gross proceeds to the Corporation of approximately $4.0 million (the Offering).
  • In the event that the over-allotment option is exercised in full, the gross proceeds of the Offering will be approximately $4.6 million.
  • Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals.
  • Premier Health uses its proprietary PSweb software platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services.

ITHAX Acquisition Corp. Announces Closing of Upsized $241.5 Million Initial Public Offering

Retrieved on: 
Monday, February 1, 2021
Financial markets, Finance, Money, Stock market, Corporate finance, Private equity, Special-purpose acquisition company, Greenshoe, Ticker symbol

New York, NY, Feb. 01, 2021 (GLOBE NEWSWIRE) -- ITHAX Acquisition Corp. (the Company), a newly incorporated blank check company, today announced the closing of its upsized initial public offering of 24,150,000 units, including 3,150,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option.

Key Points: 
  • New York, NY, Feb. 01, 2021 (GLOBE NEWSWIRE) -- ITHAX Acquisition Corp. (the Company), a newly incorporated blank check company, today announced the closing of its upsized initial public offering of 24,150,000 units, including 3,150,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option.
  • The offering was priced at $10.00 per unit, resulting in gross proceeds of $241.5 million.
  • The Companys units commenced trading on the Nasdaq Capital Market (Nasdaq) under the ticker symbol ITHXU on January 28, 2021.
  • ITHAX Acquisition Corp. is a newly organized blank check company formed by the founders of Ithaca Capital and AXIA Ventures.

CA Healthcare Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering

Retrieved on: 
Friday, January 29, 2021
Banking, Professional services, Finance, Financial markets, Finance, Corporate finance, Greenshoe, Stock market, Initial public offering, NASDAQ

CA Healthcare Acquisition Corp. (the Company) announced today the completion of its initial public offering of 11,500,000 units, including 1,500,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option.

Key Points: 
  • CA Healthcare Acquisition Corp. (the Company) announced today the completion of its initial public offering of 11,500,000 units, including 1,500,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option.
  • The Companys units commenced trading on the Nasdaq Capital Market (Nasdaq) under the ticker symbol CAHCU on January 27, 2021.
  • Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of warrants, $115,000,000 (or $10.00 per unit sold in the public offering) was placed in the Companys trust account.
  • This press release contains statements that constitute forward-looking statements, including with respect to the initial public offering and the anticipated use of net proceeds.

DIRTT announces exercise in full of Over-Allotment Option

Retrieved on: 
Friday, January 29, 2021
Financial markets, Finance, Financial economics, Stock market, Initial public offering, Corporate finance, Greenshoe, Stock, NASDAQ, Subscription, Option

As a result of the Underwriters' exercise of the Over-Allotment Option in full, the aggregate gross proceeds of the Offering were C$40.25 million.

Key Points: 
  • As a result of the Underwriters' exercise of the Over-Allotment Option in full, the aggregate gross proceeds of the Offering were C$40.25 million.
  • DIRTT is a building process powered by technology.
  • DIRTT trades on the Nasdaq under the symbol DRTT and on the Toronto Stock Exchange under the symbol DRT.
  • FOR MORE INFORMATION, PLEASE CONTACT Kim MacEachern Investor Relations, DIRTT 403.618.4539 [email protected]

Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Friday, January 29, 2021
Financial markets, Financial economics, Finance, Stock market, Corporate finance, Initial public offering, Stock, Short, Greenshoe

All shares of common stock to be sold in the public offering are being sold by Adamis.

Key Points: 
  • All shares of common stock to be sold in the public offering are being sold by Adamis.
  • The offering is expected to close on February 2, 2021, subject to the satisfaction of customary closing conditions.
  • The company has also granted the underwriters a 30-day option to purchase up to 6,081,081 additional shares of its common stock to cover over-allotments, if any.
  • Raymond James & Associates, Inc. is acting as the sole book-running manager for the offering.

Drive Shack Inc. Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Friday, January 29, 2021
Construction & Property, Sports, Finance, Entertainment, Banking, Golf, Professional services, General Entertainment, Other Construction & Property, Financial markets, Finance, Financial economics, Corporate finance, Stock market, Initial public offering, Legal entities, Stock, American International Group, Limited liability company, Greenshoe

All shares of common stock are being offered by the Company.

Key Points: 
  • All shares of common stock are being offered by the Company.
  • The Company has granted the underwriters an option for a period of 30 days to purchase up to an additional 3,124,999 shares of common stock.
  • The offering is expected to close on February 2, 2021, subject to customary closing conditions.
  • BTIG, LLC is acting as lead book-running manager and Craig-Hallum Capital Group LLC is acting as joint book-running manager for the offering.

Outlook Therapeutics Increases Previously Announced Bought Deal Offering of Common Stock to $35.0 Million

Retrieved on: 
Friday, January 29, 2021
Financial markets, Finance, Financial economics, Stock market, Corporate finance, Initial public offering, Contract law, Public offering, Stock, Underwriting, Option, Greenshoe

Outlook Therapeutics also has granted to the underwriter a 30-day option to purchase up to an additional 5,250,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

Key Points: 
  • Outlook Therapeutics also has granted to the underwriter a 30-day option to purchase up to an additional 5,250,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
  • The gross proceeds to Outlook Therapeutics, before deducting underwriting discounts and commissions and offering expenses and assuming no exercise of the underwriter's option to purchase additional common stock, are expected to be approximately $35.0 million.
  • Ltd., has indicated an interest in purchasing directly or through an affiliate up to $8.36 million of the shares of common stock offered in the offering at the public offering price per share.
  • The shares of common stock are being offered by Outlook Therapeutics pursuant to a registration statement on Form S-3 (File No.

Northern Star Investment Corp. II Announces Closing of Upsized $400,000,000 Initial Public Offering

Retrieved on: 
Thursday, January 28, 2021
Banking, Other Professional Services, Professional services, Finance, Financial markets, Finance, Financial economics, Corporate finance, Stock market, Private equity, Special-purpose acquisition company, Greenshoe, Initial public offering, Offering, Underwriting

Northern Star Investment Corp. II (the Company) announced today that it consummated its upsized initial public offering of 40,000,000 units, including 5,000,000 units subject to the underwriters over-allotment option, at $10.00 per unit.

Key Points: 
  • Northern Star Investment Corp. II (the Company) announced today that it consummated its upsized initial public offering of 40,000,000 units, including 5,000,000 units subject to the underwriters over-allotment option, at $10.00 per unit.
  • Northern Star Investment Corp. II is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities.
  • This press release contains statements that constitute forward-looking statements, including with respect to the proposed initial public offering and the anticipated use of net proceeds.
  • No assurance can be given that the net proceeds of the offering will be used as indicated.

Science Strategic Acquisition Corp. Alpha Announces Closing of $310.5 Million Initial Public Offering and Full Exercise of Underwriter’s Over-Allotment Option

Retrieved on: 
Thursday, January 28, 2021
Financial markets, Finance, Stock market, Money, Initial public offering, Greenshoe, Ticker symbol, Underwriting, Subscription

SANTA MONICA, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Science Strategic Acquisition Corp. Alpha (the Company)announced today that it closed its initial public offering of 31,050,000 units at $10.00 per unit, including 4,050,000 units sold pursuant to the underwriters exercise of the over-allotment option in full.

Key Points: 
  • SANTA MONICA, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Science Strategic Acquisition Corp. Alpha (the Company)announced today that it closed its initial public offering of 31,050,000 units at $10.00 per unit, including 4,050,000 units sold pursuant to the underwriters exercise of the over-allotment option in full.
  • The gross proceeds from the offering were $310.5 million before deducting underwriting discounts and estimated offering expenses.
  • The units began trading on the Nasdaq Capital Market under the ticker symbol SSAAU on January 26, 2021.
  • Each unit consists of one share of the Companys Class Acommon stock and one-third of oneredeemable warrant.